Lower Incidence of Hypoglycemia With Angiotensin Receptor Blocker Versus ACE Inhibitor Therapy in People With or Without Diabetes

Israel Khanimov, Boris Zingerman, Benaya Rozen-Zvi, Mordechai Shimonov, Eyal Leibovitz*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

This article describes a study examining the association between treatment with ACE inhibitors or angiotensin receptor blockers (ARBs) and incident hypoglycemia in patients with or without diabetes who were admitted to the internal medicine departments of a tertiary hospital in the Tel Aviv district of Israel. The authors found that treatment with ARBs, but not ACE inhibitors, compared with treatment with neither, was associated with a reduced risk of hypoglycemia regardless of diabetes status.

Original languageEnglish
Pages (from-to)300-307
Number of pages8
JournalClinical Diabetes
Volume42
Issue number2
DOIs
StatePublished - Mar 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Lower Incidence of Hypoglycemia With Angiotensin Receptor Blocker Versus ACE Inhibitor Therapy in People With or Without Diabetes'. Together they form a unique fingerprint.

Cite this